EMD-71588

Single-particle
11.6 Å
EMD-71588 Deposition: 03/07/2025
Map released: 24/12/2025
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-71588

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Negative stain EM map of EBV glycoprotein gH/gL in complex with glycoprotein gp42 and FAB ATX-42-2 closed conformation

EMD-71588

Single-particle
11.6 Å
EMD-71588 Deposition: 03/07/2025
Map released: 24/12/2025
Last modified: 08/07/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: human gammaherpesvirus 4, Mus musculus
Sample: coexpress glycoprotein gh/gL complex 1:1 with glycoprotein gp42, then complex 1:1 with FAB ATX-42-2

Deposition Authors: Lang K , Kher G , Chan CB , Pancera M
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.
PUBMED: 41707657
DOI: doi:10.1016/j.xcrm.2026.102618
ISSN: 2666-3791